New Initiatives Aim To Emancipate 'Scientist-Programmers'

Cornell University’s Eldredge Bermingham spends hours each day, against his will, in front of a computer. Bermingham isn’t a reluctant computer scientist; he’s just a biologist who needs some good software. He uses the latest techniques in molecular genetics to understand how new species are formed. His work requires computer programs so specialized that most of them aren’t available commercially. So Bermingham has to write his own, or hire programmers to help him. Ove

Written byChristopher Anderson
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Cornell University’s Eldredge Bermingham spends hours each day, against his will, in front of a computer. Bermingham isn’t a reluctant computer scientist; he’s just a biologist who needs some good software. He uses the latest techniques in molecular genetics to understand how new species are formed.

His work requires computer programs so specialized that most of them aren’t available commercially. So Bermingham has to write his own, or hire programmers to help him. Overseeing the process often takes a quarter of his working day and keeps him from his laboratory. “It’s just a gross expense of time,” he complains.

Berrningham is one of a swelling number of researchers who have experienced the dark side of the computer revolution. As workstations and PCs infiltrate nearly every corner of scientific endeavor and grow ever more powerful and capable, scientists are spending more time trying to satisfy their machine’s insatiable appetite for better ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies